Keywords: genaera, initiates, dosing, ph, trodusquemine, trial, pennsylvania

Genaera initiates dosing in Ph I trodusquemine trial

Article | 28 May 2007

Print This

Pennsylvania, USA-based Genaera says that dosing of subjects has begun in study MSI-1436C-101, the Phase I, first-in-man trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in